Mustang Bio Inc. (MBIO)
NASDAQ: MBIO
· Real-Time Price · USD
1.57
-0.01 (-0.63%)
At close: Oct 06, 2025, 1:10 PM
-0.63% (1D)
Bid | 1.56 |
Market Cap | 11.36M |
Revenue (ttm) | 1.99M |
Net Income (ttm) | -3.28M |
EPS (ttm) | 1.99 |
PE Ratio (ttm) | 0.79 |
Forward PE | -0.02 |
Analyst | n/a |
Dividends | n/a |
Ask | 1.57 |
Volume | 54,373 |
Avg. Volume (20D) | 5,164,235 |
Open | 1.55 |
Previous Close | 1.58 |
Day's Range | 1.54 - 1.59 |
52-Week Range | 0.89 - 21.95 |
Beta | 2.30 |
Ex-Dividend Date | n/a |
About MBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MBIO
Website n/a
3 months ago
+180.67%
Mustang Bio shares are trading higher after the co...
Unlock content with
Pro Subscription
3 months ago
+114.64%
Mustang Bio shares are trading higher after the company announced it received FDA Orphan Drug designation status for MB-101.